Glimepiride Tablet
Product Images NDC 43063-630

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 43063-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063630)

This is a medication warning for GLIMEPIRIDE, a tablet medication used for managing blood sugar levels in people with type 2 diabetes. The text includes dosage and storage instructions, as well as a reminder to keep the medication out of reach of children. It advises to call a doctor for medical advice about side effects and to report them to the FDA. The tablets contain 2 MG of GLIMEPIRIDE, and the bottle includes 30 tablets with a re-order number of 109061. The LOT number is G18E36, and the medication expires on 07/20. There is an organoleptic marking of "AHI2" on the green, oval shaped tablet with a break line. The pharmaceutical company is incorporated in Oklahoma City, OK.*

FDA Label Image

Structure (Glimepiride Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.